HK1137352A1 - 至少種肉毒杆菌神經毒素在治療由至少種抗腫瘤藥引起的疼痛中的治療應用 - Google Patents
至少種肉毒杆菌神經毒素在治療由至少種抗腫瘤藥引起的疼痛中的治療應用Info
- Publication number
- HK1137352A1 HK1137352A1 HK10101268.1A HK10101268A HK1137352A1 HK 1137352 A1 HK1137352 A1 HK 1137352A1 HK 10101268 A HK10101268 A HK 10101268A HK 1137352 A1 HK1137352 A1 HK 1137352A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- therapeutic use
- antineoplastic agent
- pain induced
- botulic neurotoxin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609435A FR2907680B1 (fr) | 2006-10-27 | 2006-10-27 | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
PCT/FR2007/001773 WO2008059126A1 (fr) | 2006-10-27 | 2007-10-26 | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1137352A1 true HK1137352A1 (zh) | 2010-07-30 |
Family
ID=38109619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10101268.1A HK1137352A1 (zh) | 2006-10-27 | 2010-02-04 | 至少種肉毒杆菌神經毒素在治療由至少種抗腫瘤藥引起的疼痛中的治療應用 |
Country Status (13)
Country | Link |
---|---|
US (1) | US8273359B2 (zh) |
EP (1) | EP2083837B1 (zh) |
JP (1) | JP5386359B2 (zh) |
CN (1) | CN101541336B (zh) |
CA (1) | CA2667128C (zh) |
DK (1) | DK2083837T3 (zh) |
ES (1) | ES2532850T3 (zh) |
FR (1) | FR2907680B1 (zh) |
HK (1) | HK1137352A1 (zh) |
PL (1) | PL2083837T3 (zh) |
PT (1) | PT2083837E (zh) |
RU (1) | RU2483747C2 (zh) |
WO (1) | WO2008059126A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
FR2889936B1 (fr) * | 2005-09-01 | 2007-12-21 | Sod Conseils Rech Applic | Methode pour quantifier une neurotoxine cholinergique dans un echantillon |
FR2902341B1 (fr) * | 2006-06-16 | 2011-02-25 | Scras | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace |
FR2907680B1 (fr) * | 2006-10-27 | 2012-12-28 | Scras | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
JP5634675B2 (ja) * | 2006-10-27 | 2014-12-03 | 一般財団法人化学及血清療法研究所 | 乳児ボツリヌス症原因菌由来の高度精製a型ボツリヌス毒素製剤 |
FR2910327B1 (fr) * | 2006-12-22 | 2013-04-26 | Scras | Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida. |
FR2930447B1 (fr) * | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique |
US20100332337A1 (en) * | 2009-06-25 | 2010-12-30 | Bullock Roddy Mckee | Universal one-click online payment method and system |
ES2847241T3 (es) | 2012-05-30 | 2021-08-02 | Harvard College | Neurotoxina botulínica genéticamente modificada |
ES2642916T3 (es) * | 2014-06-06 | 2017-11-20 | Galit KLEINER-FISMAN | Toxina botulínica para su uso en el tratamiento de la paratonia |
CN115925835A (zh) | 2015-03-26 | 2023-04-07 | 哈佛大学校长及研究员协会 | 工程改造的肉毒杆菌神经毒素 |
WO2017143316A1 (en) | 2016-02-19 | 2017-08-24 | Avery Dennison Corporation | Two stage methods for processing adhesives and related compositions |
US11117935B2 (en) | 2016-08-24 | 2021-09-14 | President And Fellows Of Harvard College | Engineered botulinum neurotoxin |
US10640595B2 (en) | 2016-10-25 | 2020-05-05 | Avery Dennison Corporation | Controlled architecture polymerization with photoinitiator groups in backbone |
WO2021173916A1 (en) * | 2020-02-27 | 2021-09-02 | President And Fellows Of Harvard College | Nociceptor neurons control cancer immunosurveillance |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2339865T3 (es) * | 1993-12-28 | 2010-05-26 | Allergan, Inc. | Uso del componente neurotoxico de toxinas botulinicas para el tratamiento de musculos espasticos. |
DE19501266A1 (de) * | 1995-01-18 | 1996-07-25 | Madaus Ag | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln |
SE9803239D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
US6113915A (en) * | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
US6139845A (en) * | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
PT1253932E (pt) | 2000-02-08 | 2005-07-29 | Allergan Inc | Composicoes farmaceuticas de toxina botulinica |
US7780967B2 (en) | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US6464986B1 (en) * | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US20020192239A1 (en) * | 2001-01-09 | 2002-12-19 | Borodic Gary E. | Use of botulinum toxin for the treatment of chronic facial pain |
KR20030018827A (ko) | 2001-08-31 | 2003-03-06 | 서구일 | A형 보툴리눔 독소를 유효성분으로 포함하는 신경차단제,및 이를 이용한 교감신경절 차단의 적응질환 치료제 |
CA2369810C (en) * | 2002-01-30 | 2007-08-07 | 1474791 Ontario Limited | Method of treating pain |
US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
US20050152905A1 (en) * | 2002-08-22 | 2005-07-14 | Omoigui Osemwota S. | Method of biochemical treatment of persistent pain |
WO2004075832A2 (en) | 2003-02-27 | 2004-09-10 | Lucas John M | Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof |
US20040247623A1 (en) | 2003-03-24 | 2004-12-09 | Roger Cady | Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
US7270287B2 (en) | 2004-01-06 | 2007-09-18 | Allergan, Inc. | Botulinum toxin treatment for kinesia |
GB2417419A (en) | 2004-07-12 | 2006-03-01 | Ipsen Ltd | Therapeutic use of Botulinum toxin |
GB2419526A (en) | 2004-10-28 | 2006-05-03 | Ipsen Ltd | Pharmaceutical composition containing botulinum neurotoxin |
GB2416692A (en) | 2004-08-04 | 2006-02-08 | Ipsen Ltd | Pharmaceutical composition containing botulinum neurotoxin |
EP1799264A2 (en) * | 2004-10-08 | 2007-06-27 | Neuromolecular Pharmaceuticals Inc | Methods and compositions for treating migraine pain |
CA2597244A1 (en) * | 2005-03-03 | 2006-09-14 | Universite Catholique De Louvain | Methods and compositions for the treatment of cancer |
WO2006122123A2 (en) * | 2005-05-09 | 2006-11-16 | Levin Bruce H | Methods of alleviating disorders and their associated pain |
KR100726441B1 (ko) * | 2005-11-22 | 2007-06-11 | 삼성전자주식회사 | 현상장치 및 이를 이용한 화상형성장치 |
FR2902341B1 (fr) | 2006-06-16 | 2011-02-25 | Scras | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace |
FR2907680B1 (fr) * | 2006-10-27 | 2012-12-28 | Scras | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux |
FR2910327B1 (fr) * | 2006-12-22 | 2013-04-26 | Scras | Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida. |
FR2930447B1 (fr) * | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique |
-
2006
- 2006-10-27 FR FR0609435A patent/FR2907680B1/fr not_active Expired - Fee Related
-
2007
- 2007-10-26 JP JP2009533902A patent/JP5386359B2/ja not_active Expired - Fee Related
- 2007-10-26 EP EP07866446.3A patent/EP2083837B1/fr active Active
- 2007-10-26 WO PCT/FR2007/001773 patent/WO2008059126A1/fr active Application Filing
- 2007-10-26 RU RU2009120021/15A patent/RU2483747C2/ru active
- 2007-10-26 US US12/447,443 patent/US8273359B2/en active Active
- 2007-10-26 CN CN2007800399471A patent/CN101541336B/zh not_active Expired - Fee Related
- 2007-10-26 ES ES07866446.3T patent/ES2532850T3/es active Active
- 2007-10-26 PL PL07866446T patent/PL2083837T3/pl unknown
- 2007-10-26 PT PT07866446T patent/PT2083837E/pt unknown
- 2007-10-26 DK DK07866446.3T patent/DK2083837T3/en active
- 2007-10-26 CA CA2667128A patent/CA2667128C/fr not_active Expired - Fee Related
-
2010
- 2010-02-04 HK HK10101268.1A patent/HK1137352A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2907680B1 (fr) | 2012-12-28 |
CN101541336B (zh) | 2012-12-19 |
CA2667128C (fr) | 2017-08-29 |
US20100068231A1 (en) | 2010-03-18 |
CA2667128A1 (fr) | 2008-05-22 |
PL2083837T3 (pl) | 2015-06-30 |
JP5386359B2 (ja) | 2014-01-15 |
US8273359B2 (en) | 2012-09-25 |
RU2483747C2 (ru) | 2013-06-10 |
JP2010507635A (ja) | 2010-03-11 |
DK2083837T3 (en) | 2015-03-23 |
RU2009120021A (ru) | 2010-12-10 |
ES2532850T3 (es) | 2015-04-01 |
WO2008059126A1 (fr) | 2008-05-22 |
EP2083837A1 (fr) | 2009-08-05 |
EP2083837B1 (fr) | 2015-01-07 |
FR2907680A1 (fr) | 2008-05-02 |
CN101541336A (zh) | 2009-09-23 |
PT2083837E (pt) | 2015-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1137352A1 (zh) | 至少種肉毒杆菌神經毒素在治療由至少種抗腫瘤藥引起的疼痛中的治療應用 | |
GB0602178D0 (en) | Therapeutic treatment | |
EP1985302A4 (en) | DRUGS FOR TUMOR THERAPY AND ITS USE | |
IL185462A0 (en) | New pharmaceutical compositions useful in the treatment of pain | |
GB0625659D0 (en) | Therapeutic compounds and their use | |
IL186616A (en) | Spyro-oxa-indoles and their use as drugs | |
SI1978947T1 (sl) | Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij | |
IL201422A0 (en) | Therapeutic agents useful for treating pain | |
PT2101731T (pt) | Endoxifeno para utilização no tratamento de cancro | |
GB0608655D0 (en) | Therapeutic Treatment | |
HK1129844A1 (en) | Use of l-cytosine nucleoside analogs in the manufacture of a medicament for use in treating cancer and other conditions or disease states l- | |
EP2219448A4 (en) | THERAPEUTIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASES AND SUFFERINGS | |
HK1209053A1 (zh) | 地來西坦在慢性疼痛的治療中的用途 | |
EP2148667A4 (en) | USE OF CYCLOHEXANHEXOL DERIVATIVES IN THE TREATMENT OF EYE DISEASES | |
GB0610909D0 (en) | Therapeutic treatment | |
IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
ZA200810199B (en) | Rinse-off therapeutic agents for treating skin | |
ZA200709542B (en) | Combination therapy in the treatment of cancer | |
IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
EP2005964A4 (en) | MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF | |
GB0710277D0 (en) | Use of antivirals in the treatment of medical disorders | |
EP1908467A4 (en) | HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN | |
GB0425633D0 (en) | Topical formulations for use in the treatment or prevention of dermatological conditions | |
EP1900363A4 (en) | THERAPEUTIC AGENT AGAINST PAIN | |
GB0509911D0 (en) | Medical treatment aid for use in treating children |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211026 |